These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15230126)

  • 41. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus.
    Font J; Ramos-Casals M; Brito-Zerón P; Nardi N; Ibañez A; Suarez B; Jiménez S; Tàssies D; García-Criado A; Ros E; Sentís J; Reverter JC; Lozano F
    Rheumatology (Oxford); 2007 Jan; 46(1):76-80. PubMed ID: 16801331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
    Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
    Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus.
    Urquizu-Padilla M; Balada E; Cortés F; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
    J Rheumatol; 2009 May; 36(5):953-60. PubMed ID: 19332622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The levels of plasminogen and inhibitor of plasminogen activators of type 1 in antiphospholipid syndrome].
    Ter Arkh; 2012; 84(5):50-7. PubMed ID: 22830213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical and immunological characteristics of primary and secondary antiphospholipid syndrome].
    Sulut'ian AE; Chapaeva NN; Shirinskiĭ VS; Kozhevnikov VS; Kozlov VA
    Klin Med (Mosk); 2004; 82(8):39-43. PubMed ID: 15468724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
    Leaños-Miranda A; Cárdenas-Mondragón G
    Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Paran D; Caspi D; Levartovsky D; Elkayam O; Kaufman I; Litinsky I; Keren G; Koifman B
    Ann Rheum Dis; 2007 Apr; 66(4):506-10. PubMed ID: 17079247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
    Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
    Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Is the primary antiphospholipid syndrome a forerunner of SLE?].
    Tarr T; Muzes G; Pitlik E; Lakos G; Csépány T; Soltész P; Zeher M; Szegedi G; Kiss E
    Orv Hetil; 2005 Jan; 146(5):203-7. PubMed ID: 15773587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus.
    Kurosaka D; Yasuda J; Yoshida K; Yoneda A; Yasuda C; Kingetsu I; Toyokawa Y; Yokoyama T; Saito S; Yamada A
    J Rheumatol; 2006 Jun; 33(6):1102-7. PubMed ID: 16755657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
    Annese V; Tomietto P; Venturini P; D'Agostini S; Ferraccioli G
    Reumatismo; 2006; 58(1):50-8. PubMed ID: 16639488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
    Giles I; Rahman A
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):525-37. PubMed ID: 19591782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
    Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
    J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus.
    Booth S; Chohan S; Curran JC; Karrison T; Schmitz A; Utset TO
    Arthritis Rheum; 2007 Jun; 57(5):845-50. PubMed ID: 17530685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
    Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
    Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating osteoprotegerin levels are elevated and correlated with antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Kwok SK; Shin YJ; Kim HJ; Kim HS; Kim JY; Yoo SA; Choi JJ; Kim WU; Cho CS
    Lupus; 2009 Feb; 18(2):133-8. PubMed ID: 19151114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.